COST-EFFECTIVENESS ANALYSIS BIAYA PENGOBATAN EPILEPSI JENIS GRAND MAL DENGAN BEBERAPA OBAT ANTI EPILEPSI DI RAWAT INAP RSUD SIDOARJO

Article Sidebar

PDF
Published: Dec 31, 2021
DOI: https://doi.org/10.61609/afamedis.v2i2.41
Keywords:
Cost-effectiveness analysis, Combination Na Fenitoin Valproic Acid, Epileptic

Main Article Content

Andri Priyoherianto
Ismu dwi supangkat

Abstract

Epilepsy is a neurological disoder that arises suddenly and periodically, ussualy with change in consciousesness. Different use of anti-epileptic drugs by patients results in patient’s medical cost increase. The use expensive anti-epileptic drugs does not guarantee the effectiveness of patient care, therefore a research needs to be done to determine which anti-epileptic drugs therapy is more cost-effective between Valproic Acid, Na Fenitoin, and combination Na Fenitoin + Valproic Acid in hospitalized epileptic patients in RSUD Sidoarjo.


The Research was a retrospective observational study with retrospective data retrieval. The research was conducted a medical Record retrieval at SIM RS from January 2020- December 2020. The samples in this study were 30 patients with 7 patients using Valproic Acid, 6 patients using Na Fenitoin, and 17 patient using combination Na Fenitoin + Valproic Acid. The results showed that the more cost- effective therapy between Valproic Acid, Na Fenitoin and combination Na Fenitoin


+ Valproic Acid in the treatment of epileptic in RSUD Sidoarjo was therapy with combination Na Fenitoin + Valproic Acid, which can be seen from ACER ( Average Cost-Effectiveness Ratio) combination Na Fenitoin + Valproic Acid Rp Rp. 880.854 /effectiveness compared with Valproic Acid ACER value of Rp. 977.307/effectiveness and Na Fenitoin Rp. 979.546/effectiveness. The lowest ICER value on combination Na Fenitoin + Valproic Acid was Rp.-994.290.


Keywords : Cost-effectiveness analysis, Combination Na Fenitoin + Valproic Acid, Epileptic

Downloads

Download data is not yet available.

Article Details

How to Cite
Andri Priyoherianto, & Ismu dwi supangkat. (2021). COST-EFFECTIVENESS ANALYSIS BIAYA PENGOBATAN EPILEPSI JENIS GRAND MAL DENGAN BEBERAPA OBAT ANTI EPILEPSI DI RAWAT INAP RSUD SIDOARJO. AFAMEDIS, 2(2), 55-62. https://doi.org/10.61609/afamedis.v2i2.41
Issue
Vol. 2 No. 2 (2021): Jurnal Farmasi Indonesia Afamedis
Section
Articles

References

Efektivitas Biaya (Aeb, Cost- Effectiveness Analysis/cea) Penggunaan Antibiotik Pada Pasien Ulkus Kaki Diabetikum Di Rsup Dr. Wahidin Sudirohusodo
Makassar” Fakultas Kedokteran dan `Ilmu Kesehatan Universitas Islam Negeri Alauddin Makassar
Ekaputri Hz, Tia Wida Eka putri Hz. Larassati. Verbty, Nur Amaliah Verbty. Kusdyah, Erny .2018. “Karakteristik Pasien Epilepsi Di RumahSakit Kota Jambi Periode Januari Sampai Desember 2018”. Jurnal Medika Malahayati, Volume 4, Nomor 2, April 2020
Hidayat, Muhamad Alfen. 2018. “Cost - Effectiveness Analysis Penggunaan Antibiotik Untuk Pasien Rawat Inap Demam Tifoid Di RSUD Bangil Tahun 2016. Skripsi. Malang. Fakultas Kedokteran Dan Ilmu-Ilmu Kesehatan Universitas Islam

Negeri Maulana Malik Ibrahim Malang.
Irfana, Laily. 2018. “Epilepsi Post Trauma Dengan Gejala Psikotik”. Medical and Health Science Journal, Vol. 2, No. 2,
August 2018
Isman, Muhammad. Harsono, dan Asmedi, Ahmad. 2011. “ Cost
- Effectiveness Karbamazepin sebagai Obat Anti-epilepsi Lini Pertama”. Berkala Neurosains, Vol 13, no. 1, Oktober 2011
Izzati Shoba Maryam 1 , Ida Ayu Sri Wijayanti 2.Karakteristik Pasien Epilepsi Di Poliklinik Saraf Rumah Sakit Umum Pusat Sanglah Periode Januari- Desember 2016. Callosum Neurology Journal, Volume 1, Nomor 3: 91-96, 2018.
Tedyanto, Eric Hartono. Chandra, Laurawati. Adam, Olivia Mahardhani. 2020.
“Gambaran Penggunaan Obat Anti Epilepsi (OAE) pada Penderita Epilepsi Berdasarkan Tipe Kejang di Poli Saraf Rumkital DR. Ramelan Surabaya”. Jurnal Ilmiah Kedokteran Wijaya Kusuma 9(1): 77-84, Maret 2020.
Kementerian Kesehatan Republik Indonesia. 2013. Pedoman Penerapan Kajian Farmakoekonomi. Jakarta
Kristanto, Andre. 2017.” Epilepsi bangkitan umum tonik-klonik di UGD RSUP Sanglah Denpasar-Bali”. Intisari Sains Medis 2017, Volume 8, No. 1:
69-73
Niluh Puspita Dewi.2012.Analisis Pola Penggunaan Obat Antiepilepsi Di instalasi Rawat Inap Rumah Sakit Umum



Daerah Madani Propinsi Sulawesi Tengah. Jurnal Farmasi Muhammadiyah Kuningan 2020;5(1): 12-18
Nursalam. 2003. Konsep dan Penerapan Metodologi Penelitian Kesehatan. Edisi Revisi. Jakarta: Salemba Medika.
Permenkes RI , 2014. “Peraturan Menteri Kesehatan Republik Indonesia Nomor 5 Tahun 2014 Nomor 231 Tentang Panduan Praktik Klinis Bagi Dokter Di Fasilitas Pelayanan Kesehatan PRIMER”. Jakarta: KementErian KesehatAn RI.
Qiyaam, Rahem. Nurul, Abdul. Maria Pia, Dian. dan Lestiono. 2015. “Analisis Efektivitas Biaya (Cost Effectiveness Analysis) Penggunaan Amitryptiline Dibandingkan Carbamazepine pada Pasien Nyeri Neuropatik (Studi Kasus Di Klinik Saraf Rumkital. Dr. Ramelan Surabaya)” . Jurnal Pharmascience, Vol 2, No. 2,
Oktober 2015, hal: 47 – 55 Tjandrawinata, Raymond R. 2016.
"Peranan Farmakoekonomi dalam Penentuan
Kebijakan yang Berkaitan dengan Obat-Obatan” :Jakarta. Dexa Laboratories of Biomolecular Sciences (DLBS) Departement of
Medical Affans dan Business Development Dexa Medica Group.
Zakky. 2020. “Pengertian Variabel Menurut Para Ahli dan Secara Umum Zona Referensi llmu Pengetahuan Umum (https://www.zonareferensi.com
/) diakses pada 23 Januari 2021